SSelectStock

JSLLJeena Sikho Lifecare Limited

Healthcare · Medical Care Facilities · NSE · as of 2026-10-28 (delayed ~30 min in market hours)

Jeena Sikho Lifecare Limited trades in ayurvedic medicines in India. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support centre services. In addition, the company operates clinics under the Shuddhi Ayurveda, Shuddhi Clinics, Hospital & Institution of Integrated Medical Sciences, Shuddhi Wellness Clinics & Hospital, Shuddhi Ayurveda Panchakarma Hospital, and Shuddhi Panchakarma Day Care Clinic names. Jeena Sikho Lifecare Limited was founded in 2009 and is headquartered in Zirakpur, India.

₹345.35
▲ 0.25%
43Weak

Mkt Cap
₹4,301 Cr
P/E
18.2
P/B
9.2
Div Yield
1.32%
52W High
₹835.00
52W Low
₹331.45

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)4,300.80
P/E18.20
P/B9.22
PEG0.68
ROE %47.50
ROCE %50.80
Debt / Equity0.27
EPS18.98
Revenue Growth %28.80
Profit Growth %28.40
Dividend Yield %1.32
Promoter Holding %72.48
FII Holding %0.32
DII Holding %—
Beta1.04

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

None of the 16 pattern scanners currently detects a setup on JSLL — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.

HOLDConviction 55%

The picture

  • • Revenue growth: 28.8% YoY
  • • Profit growth: 28.4% YoY
  • • ROE: 47.5%
  • • Trend strength (ADX): 45
  • • Beta: 1.04
  • • Liquidity: ₹43.3 cr avg turnover

Bull case

  • • Revenue growth: 28.8% YoY
  • • Profit growth: 28.4% YoY
  • • ROE: 47.5%
  • • Trend strength (ADX): 45

Bear case

  • • RSI: 20
  • • MACD: bearish
  • • 1-month return: -31.2%
  • • 1-month vs NIFTY: -29.3% relative

Key risks

  • • Momentum is fading versus the broader market
  • • RSI: 20
  • • MACD: bearish

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹345.35
Stop Loss
₹328.14
risk 5%
Target 1 (1.5R)
₹371.17
+7.5%
Target 2 (3R)
₹396.99
+15.0%
Support (20d)
₹331.45
Resistance (52w)
₹835.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹17.21/share
ATR (volatility)
₹18.08
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹18.08). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental98
Technical22
Momentum1
Risk (safety)45

Peers — Healthcare

INDGN▼ 0.17%
69
LENSKART▲ 3.06%
67
SAGILITY▼ 1.67%
66
VIJAYA▲ 0.01%
65
LALPATHLAB▲ 1.08%
65
MOMSBELIEF▲ 0.26%
64